Arcellx assumed with a Neutral at Cantor Fitzgerald

Cantor Fitzgerald assumed coverage of Arcellx (ACLX) with a Neutral rating and $88 price target The shares have performed well of late and are now approaching fair value, the analyst tells investors in a research note. The firm thinks anito-cel’s profile is differentiated on safety and that efficacy in the same ballpark as Carvykti with favorable deliverability will enable it to be very competitive against Carvykti despite it coming to the market four years later.